Skip to main content
. 2023 Feb 28;83(9):1410–1425. doi: 10.1158/0008-5472.CAN-22-2589

Table 1.

. Characteristics of the included patients and their association with the Sintra/immune, Sintra/cancer, and Sintra/tissue.

Characteristics Categories Total N (%) S intra/immune P value S intra/cancer P value S intra/tissue P value
Histology (N = 935) LUSC 462 (49.41%) 0.011 0.057 0.49
LUAD 473 (50.59%)
Age (N = 934) ≥65 566 (60.6%) 0.61 0.38 0.38
<65 368 (39.4%)
Sex (N = 935) female 377 (40.32%) 0.03 0.016 0.21
male 558 (59.68%)
Smoking history (N = 903) current reformed smoker for ⇐ 15 years 394 (43.63%) 0.36 0.17 0.32
current reformed smoker for > 15 years 199 (22.04%)
current smoker 230 (25.47%)
lifelong nonsmoker 80 (8.86%)
Pack years (N = 723) ≥35 478 (66.11%) 0.23 0.12 0.20
<35 245 (33.89%)
TMB (N = 902) <3 347 (38.47%) 0.26 0.31 0.65
≥3 555 (61.53%)
Stage (N = 935) ia 214 (22.89%) 0.075 0.31 0.20
ib 257 (27.49%)
iia 114 (12.19%)
iib 159 (17.01%)
iiia 129 (13.80%)
iv 62 (6.63%)